Evoke Pharma Inc. (EVOK)
NASDAQ: EVOK
· Real-Time Price · USD
5.15
-0.05 (-0.96%)
At close: Sep 03, 2025, 3:59 PM
-0.96% (1D)
| Bid | 5.11 |
| Market Cap | 8.03M |
| Revenue (ttm) | 12.79M |
| Net Income (ttm) | -5.38M |
| EPS (ttm) | -1.25 |
| PE Ratio (ttm) | -4.12 |
| Forward PE | 8.12 |
| Analyst | n/a |
| Ask | 5.2 |
| Volume | 25 |
| Avg. Volume (20D) | 2,509,050 |
| Open | 5.29 |
| Previous Close | 5.20 |
| Day's Range | 5.15 - 5.29 |
| 52-Week Range | 1.94 - 12.32 |
| Beta | -0.04 |
About EVOK
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol EVOK
Website n/a
Next Earnings Release
Evoke Pharma Inc. is scheduled to release its earnings on
Nov 6, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
+8.75%
Shares are trading higher after the company announ...
Unlock content with
Pro Subscription
1 month ago
+162.78%
Evoke Pharma shares are trading higher after the company announced it received a notice of allowance for the U.S. patent application covering GIMOTI in patients with moderate to severe symptoms of Gastroparesis.
